Overview

Roivant Sciences Ltd. is a commercial-stage biopharmaceutical company that seeks to improve the lives of patients by accelerating the development and commercialization of medicines that...

Open

$0.00

Prior close

$39.98

Today's high

$0.00

Today's low

$0.00

52 Week high

$42.50

52 Week low

$14.50

News

Seeking Alpha • 6 days ago • ROIV

Roivant Sciences: Diverse Exposure To Biotech Niches Through Vants

Seeking Alpha • 8 days ago • ROIV

Roivant Sciences Ltd. (ROIV) Presents at Citigroup's Biopharma Back to School Summit 2026 Transcript

Seeking Alpha • 9 days ago • ROIV

Roivant Sciences Ltd. (ROIV) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference Transcript

Seeking Alpha • 10 days ago • ROIV

Roivant Sciences Ltd. (ROIV) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

Seeking Alpha • 10 days ago • ROIV

Roivant Sciences Ltd. (ROIV) Discusses Top Line Results from PHocus Study of Mosliciguat in PH-ILD Transcript